Maple Grove, MN – December 7, 2020 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that as part of its ongoing effort to reimagine prescriber education during the COVID-19 pandemic, it has launched a new and ... Read More
Tosymra®(sumatriptan nasal spray) 10 mg and Zembrace® SymTouch® (sumatriptan injection) 3 mg to be Featured at Virtual Exhibit Booth
Maple Grove, MN – November 16, 2020 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it will ... Read More
Known as the “Mother Theresa of Healthcare”, Abubakar Earns Award for Tireless Service to Community Health and Advancing Pharmacy Education
Amina Abubakar, PharmD
NCPA’s 2020 Willard B. Simmons Independent Pharmacist of the Year Award Winner
Maple Grove, ... Read More
Awardees Recognized at Cardinal Health’s Supply Chain Excellence Awards Ceremony
Maple Grove, MN – October 16, 2020 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that two of its employees have received top honors from Cardinal Health ... Read More
Maple Grove, MN and North Augusta, SC – August 7, 2020 – Upsher-Smith Laboratories, LLC (Upsher-Smith) and AmbioPharm, Inc. (AmbioPharm) today announced that the companies have entered into a partnership agreement to develop and market ... Read More
Eligible Patients Pay $0 per Prescription* for Upsher-Smith Migraine Medications
Maple Grove, MN – June 23, 2020 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced its continued commitment to people who suffer from migraines during National Migraine ... Read More
Company Strengthens Its Generic Portfolio with Rapid Product Expansion
Maple Grove, MN – February 19, 2020 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it has expanded its generic portfolio with the recent launch of three ... Read More
Awardees Selected for Their Commitment to Patients and Effort in Advancing the Pharmacy Profession
Maple Grove, MN – February 18, 2020 – Upsher-Smith Laboratories, LLC (Upsher-Smith) and the National Alliance of State Pharmacy Associations (NASPA) are ... Read More
Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it will be attending the 2019 Annual Meeting of the American Epilepsy Society (AES) December 6-10, 2019 in Baltimore, MD. Meeting attendees are encouraged to visit booth #526 ... Read More
Program Provides Access and Affordability for Patients Seeking Treatment for Acute Migraine
Maple Grove, MN – November 18, 2019 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it has added Zembrace® SymTouch® (sumatriptan) Injection 3 mg ... Read More
